| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.62 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |